Navigation Links
Blacks With Certain Gene Need Lower Doses of Warfarin: Study

WEDNESDAY, June 5 (HealthDay News) -- The discovery of a genetic variation that affects how some black patients respond to the blood thinner warfarin could improve the safety and effectiveness of the drug, researchers report.

Blacks with this common genetic variation need a significantly lower dose of warfarin than those without the variation, the researchers report online June 4 in The Lancet.

"Adding this genetic marker -- found in more than 40 percent of African-American patients in the study -- to standard dosing algorithms improved the predictability of warfarin dosing by 21 percent in these individuals, which has the potential to increase the safety and effectiveness of this notoriously hard-to- dose drug," study leader Julie Johnson, of the University of Florida, said in a journal news release.

Warfarin is widely used to prevent blood clots in patients with a heart rhythm disorder called atrial fibrillation, a history of previous blood clots and after major surgery. However, it can be difficult to determine the correct dose for individual patients.

Previous research has identified two genes that explain about 30 percent of the difference in warfarin response in people of European and Asian ancestry, but these genes have less of an effect in blacks.

In this study, the researchers analyzed health information and DNA samples from hundreds of blacks and determined that there was a strong association between the rs12777823 variant on chromosome 10 and warfarin dose. The findings suggest that the dose of warfarin required by blacks with one or two copies of this variant is about 7 milligrams (mg) to 9 mg less per week than for other patients, the researchers said.

The U.S. Food and Drug Administration advocates use of genetic backgrounds to help guide warfarin dosing, Mark Alberts, of the University of Texas Southwestern Medical Center at Dallas and author of an accompanying editorial, said in the news release. "However, the practical aspects [and limitations] have not been fully appreciated.

"Genetic testing has several challenges: it is not widely available in some areas; it is costly; and clinicians often can identify the correct dose before test results are available. If these problems were corrected, the actual use of such tests might increase substantially," Alberts noted.

More information

The American Heart Association has more about warfarin.

-- Robert Preidt

SOURCE: The Lancet, news release, June 4, 2013

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. High Blood Pressure May Be Especially Lethal for Blacks
2. Hispanic lung cancer patients tend to live longer than blacks and whites
3. Blacks and Hispanics at higher risk for precancerous colorectal polyps
4. Blacks Less Likely to Get Help on Scene After Cardiac Arrest: Study
5. Eye Changes May Predict Heart Disease in Blacks With Diabetes
6. Blacks, Hispanics Have Higher Colon Polyp Risk Than Previously Thought
7. 9 in 10 Blacks With High Blood Pressure Have Early Heart Disease
8. Marriage has different meanings for blacks and whites
9. Blacks More Prone to Hypertension After Certain Strokes
10. Stress Adds to Salt Load of Some Blacks, Study Says
11. Blacks Less Likely to Stick to High Blood Pressure Diet: Study
Post Your Comments:
Related Image:
Blacks With Certain Gene Need Lower Doses of Warfarin: Study
(Date:6/25/2016)... Viejo, California (PRWEB) , ... June 25, 2016 , ... ... to fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... fully customizable and all within Final Cut Pro X . Simply select a ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/25/2016)... ... 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland ... iHire in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness ... & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of ...
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... June ... about the dangers associated with chronic pain and the benefits of holistic treatments, ... individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Bay Area ... Network,s Dean Center for Tick Borne Illness ... and Rehabilitation, MIT Hacking Medicine, University of California, ... today announced the five finalists of Lyme ... disease.  More than 100 scientists, clinicians, researchers, entrepreneurs, ...
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical Systems ... "Company"), which develops, markets and sells medical devices and ... , signed a strategic cooperation agreement with Hongyuan Supply ... Supply Chain") on June 20, 2016, to develop Dehaier,s ... strategic cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
Breaking Medicine Technology: